John Hollister - Silicon Laboratories CFO, Senior Vice President
| SLAB Stock | USD 118.93 4.67 4.09% |
President
Mr. John C. Hollister is Chief Financial Officer, Senior Vice President of Silicon Laboratories Inc. Mr. Hollister has served Silicon Labs as our Senior Vice President and Chief Financial Officer since June 2013. Prior to this role, Mr. Hollister was our Vice President, Business Development since April 2012 and also served as our Chief Information Officer from November 2012 to June 2013. Mr. Hollister served as our Vice President, Manufacturing and Asia Operations from November 2009 to April 2012. From April 2007 to October 2009, he was Managing Director, Asia Operations. Mr. Hollister joined Silicon Labs in 2004 and held financial management positions until April 2007. Prior to joining Silicon Labs, Mr. Hollisters experience included Vice President of Finance at Cicada Semiconductor as well as various finance positions at Cirrus Logic, Veritas DGC, 3D Geophysical and PricewaterhouseCoopers LLP since 2013.
| Age | 48 |
| Tenure | 11 years |
| Address | 400 West Cesar Chavez, Austin, TX, United States, 78701 |
| Phone | 512 416 8500 |
| Web | https://www.silabs.com |
Silicon Laboratories Management Efficiency
The current year's Return On Tangible Assets is expected to grow to 0.08. The current year's Return On Capital Employed is expected to grow to 0.09. At present, Silicon Laboratories' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 78.9 M, whereas Total Assets are forecasted to decline to about 1.1 B. Silicon Laboratories' management efficiency ratios could be used to measure how well Silicon Laboratories manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Adele Ambrose | Merck Company | 59 | |
| Ron Coughlin | HP Inc | 50 | |
| Matthew McGrew | Danaher | 52 | |
| Mirian GraddickWeir | Merck Company | 62 | |
| Robert Davis | Merck Company | 54 | |
| Daniel Comas | Danaher | 55 | |
| Jennifer Zachary | Merck Company | 46 | |
| Michael Holston | Merck Company | 53 | |
| James Bergkamp | HP Inc | N/A | |
| Steven Mizell | Merck Company | 60 | |
| Brian Ellis | Danaher | 57 | |
| Richard DeLuca | Merck Company | 61 | |
| George Kadifa | HP Inc | 54 | |
| James Ditkoff | Danaher | 67 | |
| Daniel Raskas | Danaher | 54 | |
| Julie Gerberding | Merck Company | 64 | |
| Ashley Watson | Merck Company | 48 | |
| Robert Lutz | Danaher | 62 | |
| Sanat Chattopadhyay | Merck Company | 61 | |
| Adam Schechter | Merck Company | 52 | |
| Alex Cho | HP Inc | 48 | |
Management Performance
| Return On Equity | -0.0264 | ||||
| Return On Asset | -0.0046 |
Silicon Laboratories Leadership Team
Elected by the shareholders, the Silicon Laboratories' board of directors comprises two types of representatives: Silicon Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Silicon. The board's role is to monitor Silicon Laboratories' management team and ensure that shareholders' interests are well served. Silicon Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Silicon Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sumit Sadana, Director | ||
| Serena Townsend, Chief Officer | ||
| Nestor Gutierrez, Chief Policy | ||
| Gregg Lowe, Director | ||
| Brandon Tolany, Senior Vice President - Worldwide Sales | ||
| AlfEgil Bogen, Independent Director | ||
| Karuna Annavajjala, Chief Officer | ||
| Neil Kim, Independent Director | ||
| Lori Knowlton, Senior Vice President Chief People Officer | ||
| Nina Richardson, Director | ||
| Christy Wyatt, Director | ||
| Ross Sabolcik, Senior Commercial | ||
| Manish Kothari, Senior Development | ||
| Alessandro Piovaccari, CTO, Executive Officer | ||
| Tyson Tuttle, CEO, Director and Member of Equity Award Committee | ||
| Laurence Walker, Independent Director | ||
| Robert Johnson, President CEO | ||
| Mark Mauldin, Interim Officer | ||
| Navdeep Sooch, Independent Chairman of the Board | ||
| William Wood, Independent Lead Director | ||
| Sandeep Kumar, Executive Officer | ||
| Kurt Hoff, Sr. VP of Worldwide Sales | ||
| George Tuttle, President CEO, Director | ||
| Sharon Hagi, Chief Security Officer | ||
| Benny Chang, Chief Products | ||
| John Hollister, CFO, Senior Vice President | ||
| Matt Johnson, Senior Vice President and General Manager of IoT products | ||
| Daniel Cooley, Senior Vice President and Chief Strategy Officer | ||
| William Bock, Pres and Director | ||
| Megan Lueders, Chief Officer | ||
| Robert Enloe, Independent Director | ||
| Jack Lazar, Director | ||
| Austin Dean, Investor Manager | ||
| John CPA, Senior President | ||
| Nstor Ho, Chief Officer |
Silicon Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Silicon Laboratories a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0264 | ||||
| Return On Asset | -0.0046 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | (0.72) % | ||||
| Current Valuation | 3.63 B | ||||
| Shares Outstanding | 31.92 M | ||||
| Shares Owned By Insiders | 1.91 % | ||||
| Shares Owned By Institutions | 98.09 % | ||||
| Number Of Shares Shorted | 1.58 M | ||||
| Price To Earning | 260.36 X |
Currently Active Assets on Macroaxis
When determining whether Silicon Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Silicon Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Silicon Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Silicon Laboratories Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Silicon Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade Silicon Stock refer to our How to Trade Silicon Stock guide.Note that the Silicon Laboratories information on this page should be used as a complementary analysis to other Silicon Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Silicon Stock analysis
When running Silicon Laboratories' price analysis, check to measure Silicon Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silicon Laboratories is operating at the current time. Most of Silicon Laboratories' value examination focuses on studying past and present price action to predict the probability of Silicon Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silicon Laboratories' price. Additionally, you may evaluate how the addition of Silicon Laboratories to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Silicon Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Silicon Laboratories. If investors know Silicon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Silicon Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.47) | Earnings Share (1.09) | Revenue Per Share 24.596 | Quarterly Revenue Growth (0.66) | Return On Assets (0) |
The market value of Silicon Laboratories is measured differently than its book value, which is the value of Silicon that is recorded on the company's balance sheet. Investors also form their own opinion of Silicon Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Silicon Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Silicon Laboratories' market value can be influenced by many factors that don't directly affect Silicon Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Silicon Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Silicon Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silicon Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.